Procter & Gamble (NYSE:PG) Price Target Lowered to $158.00 at Wells Fargo & Company

Procter & Gamble (NYSE:PG) had its target price lowered by Wells Fargo & Company from $177.00 to $158.00 in a research note published on Wednesday morning, Marketbeat Ratings reports. The firm currently has an overweight rating on the stock.

PG has been the subject of a number of other research reports. Jefferies Financial Group upgraded Procter & Gamble from a “hold” rating to a “buy” rating and raised their target price for the stock from $156.00 to $179.00 in a research note on Tuesday, December 16th. Barclays set a $155.00 target price on Procter & Gamble in a research note on Friday, January 16th. Deutsche Bank Aktiengesellschaft reduced their target price on Procter & Gamble from $171.00 to $162.00 and set a “hold” rating for the company in a research note on Monday, March 30th. TD Cowen reduced their target price on Procter & Gamble from $156.00 to $142.00 and set a “hold” rating for the company in a research note on Wednesday, April 1st. Finally, BNP Paribas Exane reduced their target price on Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating for the company in a research note on Friday, January 16th. Twelve investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $164.79.

Procter & Gamble Stock Performance

Shares of PG stock opened at $145.00 on Wednesday. The firm has a market capitalization of $336.98 billion, a price-to-earnings ratio of 21.48, a price-to-earnings-growth ratio of 5.04 and a beta of 0.41. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.72 and a quick ratio of 0.51. The business has a fifty day moving average of $153.23 and a 200 day moving average of $149.32. Procter & Gamble has a 1 year low of $137.62 and a 1 year high of $171.65.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, January 23rd. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.86 by $0.02. The company had revenue of $22.21 billion during the quarter, compared to analyst estimates of $22.36 billion. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The firm’s quarterly revenue was up 1.5% on a year-over-year basis. During the same quarter last year, the business posted $1.88 EPS. As a group, research analysts expect that Procter & Gamble will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, February 17th. Shareholders of record on Friday, January 23rd were given a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend was Friday, January 23rd. Procter & Gamble’s dividend payout ratio (DPR) is currently 62.67%.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, insider Susan Street Whaley sold 1,809 shares of the stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $159.46, for a total transaction of $288,463.14. Following the sale, the insider directly owned 30,215 shares of the company’s stock, valued at approximately $4,818,083.90. This trade represents a 5.65% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Moses Victor Javier Aguilar sold 15,169 shares of the stock in a transaction dated Friday, February 13th. The stock was sold at an average price of $162.28, for a total value of $2,461,625.32. Following the sale, the insider directly owned 44,735 shares in the company, valued at $7,259,595.80. This represents a 25.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 348,618 shares of company stock worth $55,462,643 in the last three months. Company insiders own 0.20% of the company’s stock.

Institutional Investors Weigh In On Procter & Gamble

A number of institutional investors have recently modified their holdings of PG. Norges Bank acquired a new stake in Procter & Gamble in the 4th quarter worth about $4,664,783,000. Cardano Risk Management B.V. raised its position in shares of Procter & Gamble by 1,104.8% during the 4th quarter. Cardano Risk Management B.V. now owns 9,521,440 shares of the company’s stock valued at $1,364,518,000 after buying an additional 8,731,126 shares during the period. Auto Owners Insurance Co raised its position in shares of Procter & Gamble by 14,231.0% during the 4th quarter. Auto Owners Insurance Co now owns 3,549,645 shares of the company’s stock valued at $508,700,000 after buying an additional 3,524,876 shares during the period. Vanguard Group Inc. raised its position in shares of Procter & Gamble by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 237,459,756 shares of the company’s stock valued at $34,030,358,000 after buying an additional 2,829,151 shares during the period. Finally, Assenagon Asset Management S.A. increased its holdings in Procter & Gamble by 100.8% in the 4th quarter. Assenagon Asset Management S.A. now owns 5,460,939 shares of the company’s stock valued at $782,607,000 after purchasing an additional 2,741,924 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G announced a multi‑year, multi‑brand partnership as an official partner of the WNBA, which should boost consumer engagement and brand visibility across younger and sports audiences. P&G Enters New Era in Sports as Official Partner of the WNBA
• Positive Sentiment: UBS trimmed its price target to $166 but maintained a “buy” rating, signaling continued analyst conviction in P&G’s long‑term growth despite the lower PT. UBS PT Change
• Positive Sentiment: Wells Fargo cut its PT to $158 but kept an “overweight” rating, which reinforces a favorable view among some institutional analysts and may support buying interest. Wells Fargo Adjusts PT
• Positive Sentiment: Coverage highlighting P&G’s “lifeblood” innovation strategy and how management is leaning into new product/marketing initiatives is helping the turnaround narrative and investor sentiment. Jim Cramer on P&G Innovation Strategy
• Neutral Sentiment: Market commentary explaining why P&G outpaced the market today provides context for the move but is descriptive rather than new fundamental information. Why P&G Outpaced the Market
• Neutral Sentiment: Goldman Sachs trimmed its PT to $155 and kept a “neutral” rating — a mixed signal that lowers upside expectations but stops short of turning bearish. Goldman Sachs Adjusts PT
• Negative Sentiment: Piper Sandler cut its PT to $142 and maintained a “neutral” rating; the new PT sits below the current price, implying downside from today’s levels and adding short‑term pressure. Piper Sandler Adjusts PT
• Negative Sentiment: Recent coverage noting a day when PG shares declined reflects ongoing volatility and reminds investors that near‑term sentiment can swing on news/analyst moves. P&G Stock Sinks Coverage

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.